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Nocardia are a group of aerobic actinomycetes that are filamentous gram-positive, weakly 
acid-fast, and cause opportunistic infection in immunocompromised patients. Primary 
Nocardia infection mostly involves lung, skin and less commonly, the central nervous 
system (CNS). Among Nocardia CNS infections, spinal infection is extremely rare. We 
describe the first case of a spinal abscess caused by Nocardia nova in an immunocompetent 
patient who experienced a penetrating facial injury six months earlier. Nocardia species 
were isolated from intradural spinal abscesses and identified by 16S rRNA, hsp65 and 
secA1 sequence analyses. Surgical excision and treatment with amikacin, cefotaxime, 
and oral erythromycin was successful.
Introduction
Nocardia species are a group of aerobic actinomycetes that 
are characteristically filamentous, branching, Gram-positive 
and modified acid-fast bacillus.1 Although Nocardia normally 
exist as soil saprophytes, increasing numbers of infections 
have been observed in immunocompromised individuals. 
Tsukamura first described N. nova in 1982 as a separate 
species with distinct features from the N. asteroides complex 
and N. farcinica.2 In 1990, Yano et al. reported that N. nova had 
different DNA homology with N. asteroides (39% homology) and 
N. farcinica (20% homology).3 
It is an unusual pathogen that commonly causes 
pneumonia4 or cutaneous abscess,5 and rarely, osteomyelitis6 
or sinusitis.7 The involvement of the central nervous system 
(CNS) by Nocardia occurs in up to 20% of the patients, 
but solitary spinal abscess due to Nocardia is extremely 
rare.8-10 Nocardia spinal abscesses are typically present 
as intra-medullary or epidural lesions, usually caused by 
N. asteroides.8-10 
We were able to find only three cases of N. nova CNS 
infection in the English language literature search 
(PubMed), including two cases of brain abscess and 
one of spondylodiscitis.11-13 All three patients were 
immunocompromised, as a result of either steroid 
administrat ion,  renal  transplantat ion,  or  human 
immunodeficiency virus (HIV) infection. To our knowledge, 
however, no case of spinal abscess caused by N. nova has 
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ever been reported. Additionally, this was a case of primary 
nocardiosis without a pulmonary infection or cutaneous 
lesions, and it lacked predisposing factors, including 
immunosuppressive therapy, hematologic malignancy, and 
transplantation. 
Case presentation
A 54-year-old female visited the emergency department 
because of progressive bilateral leg weakness and 
uncontrollable bowel movements. Upon arrival, she had 
complete paraplegia in both legs without fever. Six months 
earlier, she had experienced a penetrating injury in the 
left orbital area with continuous cerebrospinal fluid (CSF) 
rhinorrhea. At that time, she was treated with antimicrobials 
for three months following surgical intervention. 
At this visit a laboratory evaluation showed a slightly 
elevated C-reactive protein level of 14.5 mg/L. The patient’s 
white blood cell (WBC) count was 7,200/mm3 with 65% 
polymorphs. Her CSF examination contained 4,046 mg/dL 
protein, 70 mg/dL glucose, and 80 WBC/mm3. A CSF smear was 
negative on both Gram and acid-fast bacillus (AFB) staining. 
Bacterial cultures of the CSF were also negative. Magnetic 
resonance imaging with gadobutrol contrast revealed a 
diffusely increased intra-medullary signal intensity from 
T7 to the cauda equina, which suggested arachnoiditis, and 
multifocal expansion with rim enhancement of the spinal cord 
at T11-L1 and L3, suggesting multiple abscesses (Fig. 1). 
The patient underwent a T11-L1 laminectomy, and spinal 
intradural and extra-medullary abscesses were removed 
from the T11-L1 level and cultured. The pus contained long 
filamentous organisms, as revealed by Gram staining. After 
three days of culture, small, wrinkled white colonies composed 
of Gram-positive cells arranged in branching filaments were 
observed. The microorganism was negative for AFB, but 
positive for modified AFB, suggesting a Nocardia species. 
Accurate identification was made by 16s rRNA, hsp65, 
and secA1 sequencing14 (Table 1). The 16S rRNA gene 
sequence (921 bp) from the isolate CBU 09/875 showed 
100% similarity with those of several N. nova strains 
including EU74135, DSM40806 and IFM0261. However, 
the strain showed similarity values of 99.56% with 
N. pseudosporangifera Z37136 and, 99.02% with N. jiangxiensis 
DQ840027, which are non-pathogenic to humans. The 
hsp65 sequence (409 bp) from the CBU 09/875 isolate 
showed the greatest similarity (99.51%) to three Nocardia 
species (N. nova AY75766527, N. veterana AY7576538 and 
N. africana AY756512). The secA1 sequence (438 bp) showed 
the greatest similarity (99.54%) to N. nova GU179114 
and N. aobensis EU178744. 
Based on our 16S rRNA, hsp65 and secA1 sequence 
analyses, we concluded that the CBU 09-875 isolate was 
N. nova. The 16S rRNA gene sequence of this isolate 
was assigned to the GenBank nucleotide sequence database 
Target Primer (5’ to 3’) PCR cycling conditions Reference
16S rRNA 27F: AGA GTT TGA TCM TGG CTC AG 5min 95°C 14
1492R: TAC GGY TAC CTT GTT ACG ACT T 35X (45s 94°C, 1min 55°C, 1min 72°C), 10min 72°C
secA1 F: GCG ACG CCG AGT GGA TGG 30s 98°C, 17
R: TTG GCC TTG ATG GCG TTG TC 35X (5s 98°C, 5s 67°C, 20s 72°C), 1min 72°C
hsp65 F: ACC AAC GAT GGT GTG TCC AT 30s 98°C, 17
 R: CTT GTC GAA CCG CAT ACC CT 35X (5s 98°C, 5s 54°C, 20s 72°C), 1min 72°C  
Table 1 - PCR primers and DNA amplification conditions for 16S rRNA, secA1 and hsp65
Fig. 1 - Sagittal T1-weighted MRI of the lumbosacral spine 
with contrast enhancement. Multifocal enhancing lesions 
are visible at levels T11-L1 and L3. Diffusely increased 
intramedullary signal intensity is evident from the lower 
thoracic level to the cauda equina.
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under accession number HM584914. The phylogenic 
relationships of isolate CBU 09-875 with other related 
Nocardia strains based on 16S rRNA gene sequences are 
shown in Fig. 2. 
The patient was treated empirically with amikacin, 
cefotaxime and vancomycin. After identification of the 
Nocardia species and antimicrobial susceptibility testing by 
disk diffusion, the regimen was changed to amikacin and 
cefotaxime for three months. The isolate was found to be 
sensitive to ampicillin, erythromycin, amikacin, imipenem, 
cefotaxime and trimethoprim-sulfamethoxazole (TMP-SXT) 
but resistant to penicillin, amoxicillin/clavulanic acid and 
tobramycin by E-test, which is compatible with the typical 
antibiotic susceptibility pattern of N. nova.15 
The patient had a favorable clinical response. Treatment 
was continued on an outpatient basis with erythromycin; 
the patient completed a year of treatment. Five months 
postoperatively, the patient had recovered sufficiently to walk 
with an aid, and had better bowel control. After one year, she 
was able to walk without support.
Discussion
Biochemical methods for identifying Nocardia species are 
limited in their ability to differentiate these organisms. 
The application of molecular methods, including sequence 
analysis of the Nocardia 16S rRNA gene, has greatly expanded 
the knowledge of the spectrum of pathogenic Nocardia 
species.16 Meanwhile, because 16S rRNA gene sequencing 
alone is sometimes insufficient for the identification of 
Nocardia species, the sequencing of other conserved regions, 
such as hsp65 and secA1, can serve as adjuncts to 16S rRNA 
sequencing.17,18 
In this case, the 16S rRNA gene sequence of CBU 09/875 
showed complete identity with N. nova and strong similarity 
(> 99%) with two other Nocardia species, which have not 
yet been reported to be responsible for human infections. 
To improve the differentiation, hsp65 and secA1 were 
sequenced, and showed the greatest similarity with N. nova, 
N. veterana and N. africana among the species pathogenic to 
humans. Based on these data, CBU 09/875 was identified as 
N. nova; this was subsequently confirmed by biochemical 
testing, including a positive two-week arylsulfatase assay 
and an inability to degrade casein, xanthine, tyrosine and 
hypoxanthine (data not shown). 
Nocardiosis is often difficult to treat; the choice of therapy 
should therefore be guided by susceptibility testing. Treatment 
with a combination of antibiotics is necessary to avoid both 
the recurrence of infection and drug resistance. Additionally, 
prolonged antibiotic therapy from six months to a year or 
longer is required, due to the slow replication rate of the 
Fig. 2 - Phylogenic tree of the current isolate (CBU 09/875) and closely related aerobic actinomycetes, including other 
Nocardia species. This neighbor-joining tree was constructed using 16S rRNA gene sequences, based on the Kimura 
two-parameter distance. Bootstrap values (%) are shown near their corresponding branches; ‘0.1’ indicates 0.1 nucleotide 
substitutions per site.
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organism.19 A three-drug regimen comprising TMP-SXT, 
amikacin, and either ceftriaxone or imipenem has been used 
successfully.19 Patients with abscesses may require surgical 
drainage to ensure the adequate penetration of antibiotics and 
clearance of the bacteria. 
N. nova is characterized by susceptibility to erythromycin, 
clarithromycin, amoxicillin, and linezolid, and by resistance 
to amoxicillin/clavulanic acid. The case we describe here 
was successfully treated with a combination of amikacin and 
cefotaxime, following by oral erythromycin based on antibiotic 
susceptibility testing. 
Human infections by Nocardia result from trauma-related 
introduction of the organism, as well as from inhalation, with 
the resulting establishment of a pulmonary focus.20 In the 
present case, the patient had a history of an orbital penetrating 
injury with CSF rhinorrhea six months prior, and since then she 
had undergone surgical intervention and antibiotic treatment 
for three months. Additionally, she lacked the predisposing 
factors for Nocardia infection, including immunosuppressive 
therapy, hematologic malignancy, transplantation, etc. 
Consequently, in this case, the spinal abscess by N. nova likely 
resulted from the previous orbital injury rather than the 
surgical intervention at that time.
This is the first reported case of a spinal abscess 
without extra-neural infection caused by N. nova in an 
immunocompetent host after a skull-penetrating injury. Rapid 
and accurate identification of the Nocardia species by various 
molecular methods including 16S rRNA, hsp65 and secA1 
sequence analyses will assist in the provision of appropriate 
treatments to patients infected with Nocardia, because the 
antimicrobial susceptibility revealed the patterns that are 
typical among Nocardia species.
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